{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:15:26Z","timestamp":1777306526712,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Clinical Research Pilot Project of Tongji hospital, Huazhong University of Science and Technology","award":["2019CR205"],"award-info":[{"award-number":["2019CR205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Increasing evidence indicates that site-distant metastases are associated with survival outcomes in patients with epithelial ovarian cancer. This study aimed to investigate the prognostic values of site-distant metastases and clinical factors and develop a prognostic nomogram score individually predicting overall survival (OS, equivalent to all-cause mortality) and cancer specific survival (CSS, equivalent to cancer-specific mortality) in patients with epithelial ovarian cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively collected data on patients with epithelial ovarian cancer from the Surveillance, Epidemiology, and End Results (SEER) database between 1975 and 2016. Multivariate Cox regression was performed to identify survival trajectories. A nomogram score was used to predict long-term survival probability. A comparison between the nomogram and the International Federation of Gynecology and Obstetrics (FIGO 2018) staging system was conducted using time-dependent receiver operating characteristic (tROC) curve.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 131,050 patients were included, 18.2, 7.8 and 66.1% had localized, regional and distant metastases, respectively. Multivariate analysis identified several prognostic factors for OS including race, grade, histology, FIGO staging, surgery, bone metastasis, liver metastasis, lung metastasis, and lymphatic metastasis. Prognostic factors for CSS included grade, site, FIGO staging, surgery, bone metastasis, brain metastasis, lung metastasis, lymphatic metastasis, and insurance. Following bootstrap correction, the C-index of OS and CSS was 0.791 and 0.752, respectively. These nomograms showed superior performance compared with the FIGO 2018 staging criteria (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A novel prognostic nomogram score provides better prognostic performance than the FIGO 2018 staging system. These nomograms contribute to directing clinical treatment and prognosis assessment in patients harboring site-distant metastases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-07977-4","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T20:02:26Z","timestamp":1621972946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study"],"prefix":"10.1186","volume":"21","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"issue":"6","key":"7977_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"7977_CR2","doi-asserted-by":"crossref","unstructured":"Doll KM, Rademaker A, Sosa JA. Practical guide to surgical data sets: Surveillance, Epidemiology, and End Results (SEER) database. JAMA surgery. 2018;153(6):588\u20139.","DOI":"10.1001\/jamasurg.2018.0501"},{"issue":"1","key":"7977_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"7977_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3322\/caac.20113","volume":"61","author":"D Jelovac","year":"2011","unstructured":"Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61(3):183\u2013203.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"7977_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ygyno.2019.08.018","volume":"155","author":"JCJ Elzakkers","year":"2019","unstructured":"Elzakkers JCJ, van der Aa MA, van Altena AM, de Hullu JA, Harmsen MG. Further insights into the role of tumour characteristics in survival of young women with epithelial ovarian cancer. Gynecol Oncol. 2019;155(2):213\u20139.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"7977_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/AOG.0000000000000981","volume":"126","author":"RD Cress","year":"2015","unstructured":"Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of long-term survivors of epithelial ovarian Cancer. Obstet Gynecol. 2015;126(3):491\u20137.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"7977_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/IGC.0b013e3181a416d0","volume":"19","author":"B Cheng","year":"2009","unstructured":"Cheng B, Lu W, Xiaoyun W, YaXia C, Xie X. Extra-abdominal metastases from epithelial ovarian carcinoma: an analysis of 20 cases. Int J Gynecol Cancer. 2009;19(4):611\u20134.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"7977_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jnci\/djy071","volume":"111","author":"LC Peres","year":"2019","unstructured":"Peres LC, Cushing-Haugen KL, K\u00f6bel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM, Doherty JA. Invasive epithelial ovarian Cancer survival by Histotype and disease stage. J Natl Cancer Inst. 2019;111(1):60\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"7977_CR9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/cncr.22919","volume":"110","author":"U Guth","year":"2007","unstructured":"Guth U, Huang DJ, Bauer G, Stieger M, Wight E, Singer G. Metastatic patterns at autopsy in patients with ovarian carcinoma. Cancer. 2007;110(6):1272\u201380.","journal-title":"Cancer"},{"issue":"3","key":"7977_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ygyno.2016.09.025","volume":"143","author":"C Marchetti","year":"2016","unstructured":"Marchetti C, Ferrandina G, Cormio G, Gambino A, Cecere S, Lorusso D, De Giorgi U, Bogliolo S, Fagotti A, Mammoliti S, et al. Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19). Gynecol Oncol. 2016;143(3):532\u20138.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"7977_CR11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00432-015-2090-3","volume":"142","author":"ML Gasparri","year":"2015","unstructured":"Gasparri ML, Grandi G, Bolla D, Gloor B, Imboden S, Panici PB, Mueller MD, Papadia A. Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer. J Cancer Res Clin Oncol. 2015;142(7):1509\u201320.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7977_CR12","doi-asserted-by":"crossref","unstructured":"Daly MC, Paquette IM. Surveillance, Epidemiology, and End Results (SEER) and SEER-Medicare databases: use in clinical research for improving colorectal cancer outcomes. Clinics in colon and rectal surgery. 2019;32(1):61\u20138.","DOI":"10.1055\/s-0038-1673355"},{"issue":"3","key":"7977_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/biostatistics\/kxy069","volume":"21","author":"M Berger","year":"2020","unstructured":"Berger M, Schmid M, Welchowski T, Schmitz-Valckenberg S, Beyersmann J. Subdistribution hazard models for competing risks in discrete time. Biostatistics. 2020;21(3):449\u201366.","journal-title":"Biostatistics"},{"issue":"4","key":"7977_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jn\/nxz268","volume":"150","author":"SK Clinton","year":"2020","unstructured":"Clinton SK, Giovannucci EL, Hursting SD. The World Cancer Research Fund\/American Institute for Cancer Research third expert report on diet, nutrition, physical activity, and Cancer: impact and future directions. J Nutr. 2020;150(4):663\u201371.","journal-title":"J Nutr"},{"issue":"31","key":"7977_CR15","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","volume":"31","author":"AA Aizer","year":"2013","unstructured":"Aizer AA, Chen M-H, McCarthy EP, Mendu ML, Koo S, Wilhite TJ, Graham PL, Choueiri TK, Hoffman KE, Martin NE, et al. Marital status and survival in patients with Cancer. J Clin Oncol. 2013;31(31):3869\u201376.","journal-title":"J Clin Oncol"},{"issue":"10","key":"7977_CR16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1158\/1055-9965.EPI-17-0290","volume":"26","author":"HK Park","year":"2017","unstructured":"Park HK, Ruterbusch JJ, Cote ML. Recent trends in ovarian Cancer incidence and relative survival in the United States by race\/ethnicity and histologic subtypes. Cancer Epidemiol Biomark Prev. 2017;26(10):1511\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"7977_CR17","doi-asserted-by":"crossref","unstructured":"Cormio G, Rossi C, Cazzolla A, Resta L, Loverro G, Greco P, Selvaggi L. Distant metastases in ovarian carcinoma. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society. 2003;13(2):125\u20139.","DOI":"10.1046\/j.1525-1438.2003.13054.x"},{"issue":"3","key":"7977_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ygyno.2019.06.014","volume":"154","author":"E Canaz","year":"2019","unstructured":"Canaz E, Grabowski JP, Richter R, Braicu EI, Chekerov R, Sehouli J. Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: an analysis of five prospective phase II\/III trials of NOGGO metadata base. Gynecol Oncol. 2019;154(3):539\u201346.","journal-title":"Gynecol Oncol"},{"key":"7977_CR19","first-page":"1","volume":"4","author":"RJ Callery","year":"2012","unstructured":"Callery RJ, Burton E, Sharan A, Yassari R, Goldberg GL. Destructive T10 vertebral lesion leads to diagnosis of metastatic ovarian cancer. Gynecol Oncol Case Rep. 2012;4:1\u20133.","journal-title":"Gynecol Oncol Case Rep"},{"issue":"3","key":"7977_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000494334","volume":"42","author":"S Keskin","year":"2019","unstructured":"Keskin S, Kucucuk S, Ak N, Atalar B, Sari M, Sozen H, Ibis K, Topuz S, Saip P. Survival impact of optimal surgical Cytoreduction in recurrent epithelial ovarian Cancer with brain metastasis. Oncol Res Treatment. 2019;42(3):101\u20136.","journal-title":"Oncol Res Treatment"},{"issue":"1","key":"7977_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","volume":"114","author":"DS Chi","year":"2009","unstructured":"Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rustum NR, Levine DA, Guile MW, Bristow RE, Aghajanian C, Barakat RR. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009;114(1):26\u201331.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"7977_CR22","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"key":"7977_CR23","doi-asserted-by":"crossref","unstructured":"Zou R, Xu H, Li F, Wang S, Zhu L. Increased expression of UBE2T predicting poor survival of epithelial ovarian cancer: based on comprehensive analysis of UBE2s, clinical samples, and the GEO database. DNA Cell Biol. 2021;40(1):36\u201360.","DOI":"10.1089\/dna.2020.5823"},{"issue":"24","key":"7977_CR24","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","volume":"34","author":"N Wentzensen","year":"2016","unstructured":"Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, et al. Ovarian Cancer risk factors by histologic subtype: an analysis from the ovarian Cancer cohort consortium. J Clin Oncol. 2016;34(24):2888\u201398.","journal-title":"J Clin Oncol"},{"issue":"5","key":"7977_CR25","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.21873\/invivo.11632","volume":"33","author":"I Steinberga","year":"2019","unstructured":"Steinberga I, Jansson K, Sorbe B. Quality indicators and survival outcome in stage IIIB-IVB epithelial ovarian Cancer treated at a single institution. In Vivo. 2019;33(5):1521\u201330.","journal-title":"In Vivo"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07977-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-07977-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07977-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T20:02:39Z","timestamp":1621972959000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07977-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7977"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07977-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"8 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research project was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. Permission for collection and analysis of the data has been authorized by the Surveillance, Epidemiology, and End Results Program (SEER ID:15914-Nov2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"609"}}